AI Discovery: Antibiotic Effective Against Lethal Superbugs

AI Discovery: Antibiotic Effective Against Le...

Up next

Meta Manus Desktop App, Anthropic Enterprise Lead, OpenAI AWS Deal

In this episode, we discuss Meta's new Manus desktop AI agent and its implications for AI as an operating system layer. We also cover startup Niv AI addressing AI data center energy consumption, Memories AI's visual memory layer for robotics, and Anthropic's dominance in new ente ...  Show more

Senators Say "Shut AI Down", Mistral Forage, Pentagon AI, Google AI

In this episode, we explore Mistral's new 'Forage' platform for custom AI models, the Pentagon's development of AI alternatives to Anthropic, and Google's expansion of its personal intelligence features. We also cover updates on BuzzFeed's 'AI slop apps' and the controversy surro ...  Show more

Recommended Episodes

176 - A New Way to Fight Super Bacteria
All Around Science

On today’s episode: Evolution may not be quite as random as we thought. A new drug is being developed to help deal with the problem of antibiotic resistance. All that and more today on All Around Science...

RESOURCES

<ul> <li dir="ltr">   Show more

AI Helps with Brain Cancer Treatments, Hospitals Testing Google's Med-PaLM 2 AI Chatbot
AI Chat: ChatGPT, AI News, Artificial Intelligence, OpenAI, Machine Learning

In this episode, we delve into the cutting-edge applications of AI in brain cancer treatments, exploring how advanced technologies are making strides in the medical field. We'll also examine the real-world testing of Google's Med-PaLM 2 AI Chatbot in hospitals and discuss its pot ...  Show more

Neue Antibiotika: Das Arsenal der Zukunft
AMBOSS Podcast – Ärztliches Wissen für Klinik und Praxis

Weltweit sterben mehr Menschen an multiresistenten Keimen als an AIDS – Tendenz steigend. Was haben wir ihnen künftig noch entgegenzusetzen? 

Nvidia Invests $50M into AI Drug Discovery Firm Recursion
Artificial Intelligence: AI News, ChatGPT, OpenAI, LLM, Anthropic, Claude, Google AI

Dive into the future of pharmaceutical innovation as Nvidia commits a significant $50 million investment into Recursion, a pioneering AI drug discovery firm. Explore the potential breakthroughs and advancements at the intersection of artificial intelligence and life-saving med ...

  Show more